Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

ILC2s regulate a fibroblast progenitor niche in the pancreas.

Science (New York, N.Y.)·2026
Same author

Cardiovascular Organoids With Adjustable Endothelial Composition via SOX17-Engineered hPSCs.

Biotechnology and bioengineering·2026
Same author

Unconventional auricular reconstruction using controlled scaffold buckling and chondrogenic cocktail containing muscle-derived cells.

Bioactive materials·2026
Same author

Gas vesicle-expressing human pluripotent stem cells enable multimodal ultrasound and optical coherence tomographic imaging.

BMC biotechnology·2026
Same author

CAR-neutrophils produced in vivo to treat glioma.

Nature biomedical engineering·2026
Same author

Reconstruction of axonal collaterals from sparse locus coeruleus noradrenergic neurons reveals their non-uniform projections in the cerebral cortex.

Neuroscience·2026

Related Experiment Video

Updated: Jul 20, 2025

Isolation of Human Neutrophils from Whole Blood and Buffy Coats
08:12

Isolation of Human Neutrophils from Whole Blood and Buffy Coats

Published on: September 17, 2021

18.7K

Engineered Artificial Human Neutrophils Exhibit Mature Functional Performance.

Yun Chang1,2, Sydney N Hummel1, Monique N Watson3

  • 1Davidson School of Chemical Engineering, Purdue University, West Lafayette, Indiana 47906, United States.

ACS Synthetic Biology
|July 31, 2023
PubMed
Summary

Researchers engineered artificial neutrophils using genetic modification and nanodrugs. These novel neutrophils mimic natural neutrophil functions, offering potential for clinical applications in immunity and infection treatment.

Keywords:
G protein-coupled receptorantibacterial abilityartificial neutrophilchemotaxis abilitygene engineering

More Related Videos

Development and Identification of a Novel Subpopulation of Human Neutrophil-derived Giant Phagocytes In Vitro
10:05

Development and Identification of a Novel Subpopulation of Human Neutrophil-derived Giant Phagocytes In Vitro

Published on: January 25, 2017

15.4K
Morphological and Compositional Analysis of Neutrophil Extracellular Traps Induced by Microbial and Chemical Stimuli
14:05

Morphological and Compositional Analysis of Neutrophil Extracellular Traps Induced by Microbial and Chemical Stimuli

Published on: November 4, 2022

2.5K

Related Experiment Videos

Last Updated: Jul 20, 2025

Isolation of Human Neutrophils from Whole Blood and Buffy Coats
08:12

Isolation of Human Neutrophils from Whole Blood and Buffy Coats

Published on: September 17, 2021

18.7K
Development and Identification of a Novel Subpopulation of Human Neutrophil-derived Giant Phagocytes In Vitro
10:05

Development and Identification of a Novel Subpopulation of Human Neutrophil-derived Giant Phagocytes In Vitro

Published on: January 25, 2017

15.4K
Morphological and Compositional Analysis of Neutrophil Extracellular Traps Induced by Microbial and Chemical Stimuli
14:05

Morphological and Compositional Analysis of Neutrophil Extracellular Traps Induced by Microbial and Chemical Stimuli

Published on: November 4, 2022

2.5K

Area of Science:

  • Biotechnology
  • Immunology
  • Cell Engineering

Background:

  • Neutrophils are crucial innate immune cells with dual roles in tumor progression and infection control.
  • Clinical applications of neutrophils are hindered by their short lifespan and complex isolation procedures.
  • Genetic engineering and nanodrug systems offer novel strategies to overcome these limitations.

Discussion:

  • Engineered K562 and HL60 leukemia cells expressing hM4Di demonstrated neutrophil-like chemotaxis towards CNO.
  • These artificial neutrophils exhibited enhanced phagocytic activity against bacteria.
  • Vancomycin-loaded nanoparticles further augmented the antibacterial efficacy of engineered cells.

Key Insights:

  • Development of artificial neutrophils via genetic engineering and nanodrug integration.
  • Demonstration of chemotaxis and phagocytosis mimicking native neutrophils.
  • Enhanced antibacterial properties achieved through targeted drug delivery.

Outlook:

  • This artificial cell engineering platform opens new avenues for studying neutrophil physiology.
  • Potential for developing novel cell-based therapies for infections and immune disorders.
  • Future research may focus on refining artificial neutrophil functions and in vivo applications.